Literature DB >> 33098858

Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.

Atanu Maiti1, Wazo Myint1, Krista A Delviks-Frankenberry2, Shurong Hou3, Tapan Kanai4, Vanivilasini Balachandran1, Christina Sierra Rodriguez1, Rashmi Tripathi5, Nese Kurt Yilmaz3, Vinay K Pathak2, Celia A Schiffer3, Hiroshi Matsuo6.   

Abstract

APOBEC3G (A3G) is a single-stranded DNA (ssDNA) cytosine deaminase that can restrict HIV-1 infection by mutating the viral genome. A3G consists of a non-catalytic N-terminal domain (NTD) and a catalytic C-terminal domain (CTD) connected by a short linker. While the CTD catalyzes cytosine deamination, the NTD is believed to provide additional affinity for ssDNA. Structures of both A3G domains have been solved individually; however, a full-length A3G structure has been challenging. Recently, crystal structures of full-length rhesus macaque A3G variants were solved which suggested dimerization mechanisms and RNA binding surfaces, whereas the dimerization appeared to compromise catalytic activity. We determined the crystal structure of a soluble variant of human A3G (sA3G) at 2.5 Å and from these data generated a model structure of wild-type A3G. This model demonstrated that the NTD was rotated 90° relative to the CTD along the major axis of the molecule, an orientation that forms a positively charged channel connected to the CTD catalytic site, consisting of NTD loop-1 and CTD loop-3. Structure-based mutations, in vitro deamination and DNA binding assays, and HIV-1 restriction assays identify R24, located in the NTD loop-1, as essential to a critical interaction with ssDNA. Furthermore, sA3G was shown to bind a deoxy-cytidine dinucleotide near the catalytic Zn2+, yet not in the catalytic position, where the interactions between deoxy-cytidines and CTD loop-1 and loop-7 residues were different from those formed with substrate. These new interactions suggest a mechanism explaining why A3G exhibits a 3' to 5' directional preference in processive deamination.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APOBEC3G; HIV-1 restriction; co-crystal structure; cytosine deaminase; ssDNA binding

Year:  2020        PMID: 33098858      PMCID: PMC7771068          DOI: 10.1016/j.jmb.2020.10.020

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  110 in total

1.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

2.  Atomic force microscopy studies of APOBEC3G oligomerization and dynamics.

Authors:  Luda S Shlyakhtenko; Alexander Y Lushnikov; Atsushi Miyagi; Ming Li; Reuben S Harris; Yuri L Lyubchenko
Journal:  J Struct Biol       Date:  2013-09-18       Impact factor: 2.867

3.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

4.  An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

Authors:  Elena Harjes; Phillip J Gross; Kuan-Ming Chen; Yongjian Lu; Keisuke Shindo; Roni Nowarski; John D Gross; Moshe Kotler; Reuben S Harris; Hiroshi Matsuo
Journal:  J Mol Biol       Date:  2009-04-21       Impact factor: 5.469

5.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

6.  Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex.

Authors:  L Betts; S Xiang; S A Short; R Wolfenden; C W Carter
Journal:  J Mol Biol       Date:  1994-01-14       Impact factor: 5.469

7.  Cytidine deamination of retroviral DNA by diverse APOBEC proteins.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Nicholas O Davidson; Soo-Jin Cho; Michael H Malim
Journal:  Curr Biol       Date:  2004-08-10       Impact factor: 10.834

8.  Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.

Authors:  Hendrik Huthoff; Michael H Malim
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

9.  Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.

Authors:  Takahide Kouno; Elizabeth M Luengas; Megumi Shigematsu; Shivender M D Shandilya; JingYing Zhang; Luan Chen; Mayuko Hara; Celia A Schiffer; Reuben S Harris; Hiroshi Matsuo
Journal:  Nat Struct Mol Biol       Date:  2015-05-18       Impact factor: 15.369

10.  Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.

Authors:  Tania V Silvas; Shurong Hou; Wazo Myint; Ellen Nalivaika; Mohan Somasundaran; Brian A Kelch; Hiroshi Matsuo; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

View more
  5 in total

Review 1.  Interactions of APOBEC3s with DNA and RNA.

Authors:  Atanu Maiti; Shurong Hou; Celia A Schiffer; Hiroshi Matsuo
Journal:  Curr Opin Struct Biol       Date:  2021-01-22       Impact factor: 6.809

2.  Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.

Authors:  Fareeda M Barzak; Timothy M Ryan; Nazanin Mohammadzadeh; Stefan Harjes; Maksim V Kvach; Harikrishnan M Kurup; Kurt L Krause; Linda Chelico; Vyacheslav V Filichev; Elena Harjes; Geoffrey B Jameson
Journal:  Viruses       Date:  2022-09-06       Impact factor: 5.818

3.  Exploring ABOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer.

Authors:  Christina Papini; Zechen Wang; Shalley N Kudalkar; Travis Parke Schrank; Su Tang; Tomoaki Sasaki; Cory Wu; Brandon Tejada; Samantha J Ziegler; Yong Xiong; Natalia Issaeva; Wendell G Yarbrough; Karen S Anderson
Journal:  iScience       Date:  2022-09-05

4.  Highly-potent, synthetic APOBEC3s restrict HIV-1 through deamination-independent mechanisms.

Authors:  Mollie M McDonnell; Suzanne C Karvonen; Amit Gaba; Ben Flath; Linda Chelico; Michael Emerman
Journal:  PLoS Pathog       Date:  2021-06-25       Impact factor: 6.823

Review 5.  Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.

Authors:  Xiaojiang S Chen
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.